T1	Age 34 38	aged
E1	Age:T1 
T2	Eq-Comparison 39 58	21 years or younger
E2	Eq-Comparison:T2 Value:T46 Temporal-Unit:T47
T3	Temporal-Connection 59 70	at the time
E3	Temporal-Connection:T3 
A1	Temporal-Connection-Type-Value E3 during
T4	Study 74 84	enrollment
E4	Study:T4 
T5	Modifier 114 118	race
E5	Modifier:T5 
T6	Or 119 121	or
E6	Or:T6 
T7	Assertion 157 166	suspected
E7	Assertion:T7 
A2	Assertion-Type-Value E7 possible
T8	Or 167 169	or
E8	Or:T8 
T9	Modifier 193 202	recurrent
E9	Modifier:T9 
T10	Or 203 205	or
E10	Or:T10 
T11	Modifier 206 216	refractory
E11	Modifier:T11 
T12	Condition 217 223	cancer
E12	Condition:T12 Name:T48
T13	Eq-Comparison 251 260	scheduled
E13	Eq-Comparison:T13 Temporal-Period:T49
T14	Or 265 267	or
E14	Or:T14 
T15	Procedure 286 292	biopsy
E15	Procedure:T15 Name:T50
T16	Or 293 295	or
E16	Or:T16 
T17	Procedure 296 309	tumor excised
E17	Procedure:T17 
T18	Modifier 311 323	solid tumors
E18	Modifier:T18 
T19	Or 325 327	or
E19	Or:T19 
T20	Modifier 328 339	bone marrow
E20	Modifier:T20 
T21	Condition 340 348	aspirate
E21	Condition:T21 Name:T53
T22	Condition 350 363	blood cancers
E22	Condition:T22 Name:T54
T23	Assertion 384 394	willing to
E23	Assertion:T23 
A3	Assertion-Type-Value E23 hypothetical
T24	Observation 402 412	blood draw
E24	Observation:T24 
T25	Or 413 415	or
E25	Or:T25 
T26	Procedure 416 427	buccal swab
E26	Procedure:T26 Name:T56
T27	Assertion 428 436	done for
E27	Assertion:T27 
A4	Assertion-Type-Value E27 hypothetical
T28	Procedure 453 468	genetic testing
E28	Procedure:T28 
T29	Age 576 580	aged
E29	Age:T29 
T30	Negation 653 656	not
E30	Negation:T30 
T31	Condition 662 678	malignant tissue
E31	Condition:T31 Name:T60
T32	Condition 723 747	excised malignant tissue
E32	Condition:T32 Name:T61
T33	Negation 751 754	not
E33	Negation:T33 
T34	Assertion 755 765	sufficient
E34	Assertion:T34 
A5	Assertion-Type-Value E34 hypothetical
T35	Procedure 777 794	vivo drug testing
E35	Procedure:T35 
T36	Or 795 801	and/or
E36	Or:T36 
T37	Procedure 802 819	genetic profiling
E37	Procedure:T37 
T38	Modifier 856 862	tumors
E38	Modifier:T38 
T39	Or 863 866	and
E39	Or:T39 
T40	Condition 867 873	tumors
E40	Condition:T40 Name:T64
T41	Eq-Comparison 890 894	>90%
E41	Eq-Comparison:T41 Operator:T66 Value:T67 Unit:T68
T42	Observation 896 905	cure rate
E42	Observation:T42 
T43	And 906 910	with
E43	And:T43 
T44	Modifier 911 915	safe
E44	Modifier:T44 
T45	Procedure 916 932	standard therapy
E45	Procedure:T45 Name:T69
T46	Eq-Value 39 41	21
T47	Eq-Temporal-Unit 42 47	years
A6	Eq-Temporal-Unit-Value T47 year
T48	Condition-Name 217 223	cancer
T49	Eq-Temporal-Period 251 260	scheduled
A7	Eq-Temporal-Period-Value T49 future
T50	Procedure-Name 286 292	biopsy
T51	Condition-Name 296 309	tumor excised
T52	Condition-Name 311 323	solid tumors
T53	Condition-Name 340 348	aspirate
T54	Condition-Name 356 363	cancers
T55	Observation-Specimen 402 407	blood
T56	Procedure-Name 416 427	buccal swab
T57	Eq-Value 581 582	7
T58	Eq-Operator 583 585	to
A8	Eq-Operator-Value T58 BETWEEN
T59	Eq-Value 586 588	17
T60	Condition-Name 662 678	malignant tissue
T61	Condition-Name 731 747	malignant tissue
T62	Observation-Name 777 794	vivo drug testing
A9	Observation-Type-Value T62 lab
T63	Condition-Name 856 862	tumors
T64	Condition-Name 867 873	tumors
T65	Polarity 884 888	high
A10	Polarity-Value T65 high
T66	Eq-Operator 890 891	>
A11	Eq-Operator-Value T66 GT
T67	Eq-Value 891 893	90
T68	Eq-Unit 893 894	%
T69	Procedure-Name 925 932	therapy
